Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 5 December 2019
- Published:
05 Dec 2019 -
Author:
Mark Brewer -
Pages:
4 -
Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH